BNF 72 (British National Formulary September 2016-March 2017) - British National Formulary (Paperback)Joint Formulary Committee (editor)
- Not available
BNF 72 has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice. Access to the latest edition of the BNF is vital for healthcare professionals, as there are a large number of updates from one edition to the next.
Some of the significant content updates for BNF 72 include:
New safety information about the risk of abnormal pregnancy outcomes with sodium valproate and valproic acidUpdated guidance for conditions including asthma, obesity, coeliac disease, irritable bowel syndrome and prostate cancerNew drug monographs including edoxaban, albiglutide, dulaglutide, dasabuvir, and vortioxetineUpdated pregnancy-prevention advice for patients taking mycophenolate mofetilUpdated guidance on the risk of hepatitis B reactivation with BCR-ABL tyrosine kinase inhibitors, and pomalidomideAdvice about the risk of ulceration with nicorandil treatmentNICE guidelines including the use of vedolizumab for treating moderately to severely active Crohn's diseaseNew guidance on suspected or confirmed drug allergyEvidence grading of BNF recommendations.
Publisher: Pharmaceutical Press
Number of pages: 1472
Dimensions: 210 x 148 mm
Edition: 72nd Revised edition
You may also be interested in...
Please sign in to write a review